| Graduate |
Degree |
Year |
Mentor |
Dissertation/Thesis Title |
|
|
|
|
|
| 200. J. Phillip Kaiser |
Ph.D. |
2009 |
Gavin E. Arteel, Ph.D. |
The role of PKC-epsilon in models of alcohol- and toxin-induced liver disease |
|
|
|
|
|
| 199. Ntube Nini Olive Ngalame |
M.S. |
2009 |
J. Christopher States, Ph.D. |
Arsenic-induced developmental changes in the liver and adult cardiovascular disease |
|
|
|
|
|
| 198. Pengxiao Cao |
M.S. |
2009 |
Ramesh C. Gupta, Ph.D. |
Effect of green tea catehins and hydrolyzable tannins on benzo[a]pyrene-induced DNA adducts and structure activity relationship |
|
|
|
|
|
| 197. Shyam Sunder Basal |
M.S. |
2009 |
Ramesh C. Gupta, Ph.D. |
A novel implantable drug delivery system of curcumin for cancer chemoprevention |
|
|
|
|
|
| 196. Jean-Claude Nzimulinda |
Ph.D. |
2009 |
Zhao-Hui (Joe) Song, Ph.D. |
Ligand binding, activation, and dimerization of CB2 cannaboinoid receptor |
|
|
|
|
|
| 195. Yang Zhou |
Ph.D. |
2008 |
Y. James Kang, Ph.D. |
Copper-induced regression of cardiomyocyte hypertrophy through alteration of VEGF/VEGFR pathways |
|
|
|
|
|
| 194. Nason P. Schooler |
M.S. |
2008 |
John W. Eaton, Ph.D. |
The use of the reducing agent N-(2-mercaptopropionyl)glycine to detoxify oxidized lipids in atherosclerotic lesions |
|
|
|
|
|
| 193. Katharine Shumate Richardson |
Ph.D. |
2008 |
Wayne Zundel, Ph.D. |
Regulation of placental ribonuclease inhibitor by tumor suppressor Von Hippel-Lindau |
|
|
|
|
|
| 192. Stephanie A. Mathews |
M.S. |
2008 |
Shirish Barve, Ph.D. |
Impaired SAM metabolism and IFNα antiviral signaling: Relevance to hepatitis C virus |
|
|
|
|
|
| 191. Robert C.G. Martin, II |
Ph.D. |
2008 |
David W. Hein, Ph.D. |
Polymorphisms in manganese superoxide dismutase as a risk factor for cancer |
|
|
|
|
|
| 190. Nicole A. Lavender |
M.S. |
2008 |
La Creis R. Kidd, Ph.D. |
Joint modifying effects of variant oxidative stress factors in relation to prostate cancer |
|
|
|
|
|
| 189. Emily Roberts Esposito |
Ph.D. |
2008 |
Michele Pisano, Ph.D. |
In vivo and in vitro models for cigarette smoke-induced low birth weight and other adverse developmental outcomes |
|
|
|
|
|
| 188. Christina Blume Clark |
Ph.D. |
2008 |
Evelyne Gozal, Ph.D. |
The role of HSP90 in PC-12 cell survival |
|
|
|
|
|
| 187. Elaina Marie Chambers |
M.S. |
2008 |
Shirish Barve, Ph.D. |
Immune dysregulation and diabetes: A potential role of phosphodiesterases |
|
|
|
|
|
| 186. Thomas J. Schlierf |
M.S. |
2008 |
David W. Hein, Ph.D. |
Role of N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in breast cancer risk with exposure to aromatic and heterocyclic amine carcinogens |
|
|
|
|
|
| 185. Katherine Bourcy |
M.S. |
2008 |
Y. James Kang, Ph.D. |
The role of vascular endothelial growth factor receptors in copper-induced regression of cardiac hypertrophy |
|
|
|
|
|
| 184. Carl Alexander Carrasquer |
Ph.D. |
2008 |
Zhao-Hui (Joe) Song, Ph.D. |
Activation and regulation of cannabinoid receptors |
|
|
|
|
|
| 183. Clarisse Muenyi |
M.S. |
2008 |
J. Christopher States, Ph.D. |
Improving the efficacy of platinum chemotherapy against ovarian cancer |
|
|
|
|
|
| 182. Lindsey Jay Stallons |
M.S. |
2008 |
W. Glenn McGregor, M.D. |
Mutagenic and tumor suppressor functions of DNA polymerase iota in mammalian cells |
|
|
|
|
|
| 181. Lori M. Millner |
M.S. |
2008 |
David W. Hein, Ph.D. |
Effect of N-acetyltransferase (NAT1) polymorphism on mutagenesis and DNA adduct formation |
|
|
|
|
|
| 180. Shankang Ma |
M.S. |
2008 |
Y. James Kang, Ph.D. |
Metallothionein gene therapy for chemically-induced liver fibrosis |
|
|
|
|
|
| 179. Jean-Claude Nzimulinda |
M.S. |
2008 |
Zhao-Hui (Joe) Song, Ph.D. |
Residues accessible in the binding site crevice of transmembrane helix 2 of CB2 cannabinoid receptor |
|
|
|
|
|
| 178. Erica N. Rogers |
M.S. |
2008 |
J. Christopher States, Ph.D. |
The modulation of DNA damage by curcumin |
|
|
|
|
|
| 177. Nicholas B. Watson |
Ph.D. |
2008 |
W. Glenn McGregor, M.D. |
RAD18 is recruited to stalled DNA replication forks and is required for recruitment of accessory translesion synthesis proteins |
|
|
|
|
|
| 176. Xiaoyan (Susan) Zhang |
Ph.D. |
2008 |
David W. Hein, Ph.D. |
Characterization of N-acetyltransferase 1 (NAT1) expression in breast cancer |
|
|
|
|
|
| 175. Ya Fatou Njie |
Ph.D. |
2007 |
Zhao-Hui (Joe) Song, Ph.D. |
Cannabinoids as potential therapeutic agents for glaucoma |
|
|
|
|
|
| 174. Christelle K. Kamga |
M.S. |
2007 |
Yang Wang, Ph.D. |
UCP4 is a key regulator of mitochondrial antioxidant defense in rat PC12 cells |
|
|
|
|
|
| 173. Jianxun Wang |
M.S. |
2007 |
Paul N. Epstein, Ph.D. |
The changes of fructos-2,6-biphosphate level in transgenic mice causing cardiomyopathy |
|
|
|
|
|
| 172. Joshua M. Thornburg |
Ph.D. |
2007 |
Jason A. Chesney, M.D., Ph.D. |
Identification of aspartate aminotransferase as a novel target for anti-neoplastic research |
|
|
|
|
|
| 171. Samuel C. McNeely |
Ph.D. |
2007 |
J. Christopher States, Ph.D. |
Sensitivity to sodium arsenite depends upon susceptibility to mitotic arrest-associated apoptosis |
|
|
|
|
|
| 170. Jason M. Walraven |
Ph.D. |
2007 |
David W. Hein, Ph.D. |
Computational and functional analyses of human and rat N-acetyltransferase genetic variants N-acetyltransferase genetic variants |
|
|
|
|
|
| 169. J. Phillip Kaiser |
M.S. |
2007 |
Gavin E. Arteel, Ph.D. |
The role of PKC-epsilon in alcoholic liver disease |
|
|
|
|
|
| 168. Agata M. Habas |
Ph.D. |
2007 |
Michal Hetman, M.D., Ph.D. |
The role of GSK3β and NFATc4 in NMDA-mediated neuronal survival |
|
|
|
|
|
| 167. B. Frazier Taylor |
Ph.D. |
2007 |
J. Christopher States, Ph.D. |
Arsenite inhibition of mitotic progression |
|
|
|
|
|
| 166. LaSharon D. Mosley |
M.S. |
2007 |
Richard E. Goldstein, M.D., Ph.D. |
Estrogen receptors in thyroid cell proliferation |
|
|
|
|
|
| 165. Lu Yang |
M.S. |
2007 |
Paul N. Epstein, Ph.D. |
Protection by metallothionein from adriamycin induced nephropathy in mice and gene expression profiling during progression of diabetic nephropathy |
|
|
|
|
|
| 164. Chad A. Dumstorf |
Ph.D. |
2007 |
W. Glenn McGregor, M.D. |
Participation of mouse DNA polymerases iota, eta, and rev1 in translesion synthesis of carcinogen induced DNA adducts and carcinogenesis |
|
|
|
|
|
| 163. Kristin J. Metry |
Ph.D. |
2007 |
David W. Hein, Ph.D. |
Role of N-acetyltransferase 2 polymorphism in DNA adduct formation and mutagenesis by aromatic and heterocyclic amine carcinogens |
|
|
|
|
|
| 162. Jin Liu |
Ph.D. |
2007 |
Michael E. Brier, Ph.D. |
Design evaluation for pharmacokinetic studies in patients with renal impairment |
|
|
|
|
|
| 161. Kevyn E. Merten |
Ph.D. |
2007 |
Y. James Kang, Ph.D. |
Effect of zinc on doxorubicin-induced activation of the calcineurin signaling pathway and the relation to myocardial cell death and hypertrophy |
|
|
|
|
|
| 160. Alex Carrasquer |
M.S. |
2006 |
Zhao-Hui (Joe) Song, Ph.D. |
The effects of polymorphisms on the function of the CB2 cannabinoid receptor |
|
|
|
|
|
| 159. Afsoon Moktar |
M.S. |
2006 |
Ramesh C. Gupta, Ph.D. |
Cigarette smoking as a major cofactor in human cervical cancer |
|
|
|
|
|
| 158. Emily Roberts Esposito |
M.S. |
2006 |
M. Michele Pisano, Ph.D. |
Low birth weight-Consequences of maternal tobacco smoke exposure during embryonic and fetal development |
|
|
|
|
|
| 157. Nstang Miranda Nebane |
Ph.D. |
2006 |
Zhao-Hui (Joe) Song, Ph.D. |
Structure-activity relationship of the CB1 and CB2 cannabinoid receptors |
|
|
|
|
|
| 156. Yang Zhou |
M.S. |
2006 |
Y. James Kang, Ph.D. |
Copper inhibition of hydrogen peroxide-induced hypertrophy in H9C2 embryonic rat cardiac cells |
|
|
|
|
|
| 155. Xiaoqiang (Steven) Xu |
M.S. |
2006 |
Theresa Whei-Mei Fan, Ph.D. |
TrxR SECIS RNA synthesis and biophysical characterization |
|
|
|
|
|
| 154. Rundong (Ray) Zhang |
Ph.D. |
2006 |
Zhao-Hui (Joe) Song, Ph.D. |
Structure and function of CB2 cannabinoid receptors |
|
|
|
|
|
| 153. Sheila A. Mullins |
M.S. |
2006 |
Paul N. Epstein, Ph.D. |
Effects of fructose-2,6-bisphosphate on Akt phosporylation and insulin signaling in cardiomyocytes |
|
|
|
|
|
| 152. Joshua M. Thornburg |
M.S. |
2006 |
Jason A. Chesney, M.D., Ph.D. |
Role of lactate dehydrogenase A (LDH-A) in oncogenic transformation; Revisiting a classic enzyme |
|
|
|
|
|
| 151. Wei (Wendy) Yuan Chang |
Ph.D. |
2006 |
Theresa S. Chen, Ph.D. |
Mechanism of 4-hydroxynonenal induced toxicity in Jurkat CD4+ T lymphocytes |
|
|
|
|
|
| 150. Katharine S. Richardson |
M.S. |
2006 |
Wayne S. Zundel, Ph.D. |
Impact of von Hippel-Lindau in regulating ribonuclease activity in renal cell carcinoma |
|
|
|
|
|
| 149. Yu (Janet) Zang |
Ph.D. |
2006 |
David W. Hein, Ph.D. |
Functional characterization and mechanistic studies on single nucleotide polymorphisms of human N-acetyltransferase 2 |
|
|
|
|
|
| 148. Tanvi S. Jani |
Ph.D. |
2006 |
Shirish Barve, Ph.D. |
Role of methionine adenosyltransferase II (MAT II) and S-adenosylmethionine (SAMe) in survival of CD4+ T lymphocytes: Relevance to immune dysfunction |
|
|
|
|
|
| 147. Stephen R. Reeves |
Ph.D. |
2006 |
David Gozal, M.D. |
Chronic intermittent hypoxia and respiratory plasticity |
|
|
|
|
|
| 146. Paul C. Porter |
Ph.D. |
2005 |
J. Christopher States, Ph.D. |
Discovery and functional analysis of XPA polymorphisms and use of telomerase immortalized cells for nucleotide excision repair studies |
|
|
|
|
|
| 145. Ya Fatou Njie |
M.S. |
2005 |
Zhao-Hui (Joe) Song, Ph.D. |
Effects of the endogenous cannabinoid, noladin ether on aqueous humor outflow facility mediated by the CB1 cannabinoid receptor |
|
|
|
|
|
| 144. Molly Anne Davis |
M.S. |
2005 |
Gavin E. Arteel, Ph.D. |
Characterization of recovery from liver damage by choline deficiency: Effect of biochemical modulators of lipid metabolism? |
|
|
|
|
|
| 143. E. Cristian Campian |
Ph.D. |
2005 |
Frederick W. Benz, Ph.D. |
Acute acrylonitrile toxicity: Mechanistic Studies |
|
|
|
|
|
| 142. Anwar Husain |
Ph.D. |
2005 |
David W. Hein, Ph.D. |
Regulatory control regions of human arylamine N-acetyltransferase 1 and 2: Implications for genetic predisposition to breast cancer |
|
|
|
|
|
| 141. Xiaoyan (Susan) Zhang |
M.S. |
2005 |
David W. Hein, Ph.D. |
Role of N-acetyltransferase (NAT) polymorphism on 4,4’-methylene bis (2-chloroaniline) and 4,4’-methylenedianiline (MDA) acetylation, MDA hepatotoxicity and a proposal to study NAT expression in breast cancer |
|
|
|
|
|
| 140. Gilandra Russell |
M.S. |
2005 |
Gavin E. Arteel, Ph.D. |
Protection of cultured hepatocytes from hypoxic death by ATP-delivery with lipid vesicles |
|
|
|
|
|
| 139. Samuel C. McNeely |
M.S. |
2005 |
J. Christopher States, Ph.D. |
Arsenic: A potential chemotherapeutic for melanoma |
|
|
|
|
|
| 138. Tanvi S. Jani |
M.S. |
2005 |
Shirish Barve, Ph.D. |
Methionine adenosyltransferase IIA (MAT IIA) and S-adenosylmethionine (SAMe) are critical for the survival of CD4+ T lymphocytes |
|
|
|
|
|
| 137. Jin Liu |
M.S. |
2005 |
Michael E. Brier, Ph.D. |
An evaluation of pharmacokinetic study design for describing drug disposition in renal failure |
|
|
|
|
|
| 136. Kevyn E. Merten |
M.S. |
2005 |
Y. James Kang, Ph.D. |
Molecular mechanisms of metallothionein protection from adriamycin cardiotoxicity |
|
|
|
|
|
| 135. Jason M. Walraven |
M.S. |
2005 |
David W. Hein, Ph.D. |
Investigations of N-acetyltransferases in human hepatocytes and rat models |
|
|
|
|
|
| 134. Nicholas B. Watson |
M.S. |
2005 |
W. Glenn McGregor, M.D. |
The ubiquitin ligase RAD18 is implicated in mutagenic translesion synthesis of DNA damage in human cells |
|
|
|
|
|
| 132. Ntsang Miranda Nebane |
M.S. |
2004 |
Zhao-Hui (Joe) Song, Ph.D. |
Effects of D3.49N mutations on ligand binding and activation of the CB1 and CB2 cannabinoid receptors |
|
|
|
|
|
| 131. Xia (Clare) Shen |
Ph.D. |
2004 |
Paul N. Epstein, Ph.D. |
Mitochondrial damage and biogenesis in diabetic heart and protection by overexpression of manganese superoxide dismutase |
|
|
|
|
|
| 130. Chad A. Dumstorf |
M.S. |
2004 |
W. Glenn McGregor, M.D. |
Mutagenesis of induced tumors in murine lung |
|
|
|
|
|
| 129. Yuanqi Zhu |
Ph.D. |
2004 |
David W. Hein, Ph.D. |
Human NAT1 genetic polymorphisms: coding region & non-coding region |
|
|
|
|
|
| 128. Agata M. Habas |
M.S. |
2004 |
Michal Hetman, M.D., Ph.D. |
The role of nuclear factors of activated T-cells (NFAT) in neuronal death |
|
|
|
|
|
| 127. Yu (Cindy) Wang |
M.S. |
2004 |
David Gozal, M.D. |
Cooperative effects of amyloid beta (25-35) and hypoxia-reoxygenation on cell death in primary cultured mouse neurons of cerebral cortex |
|
|
|
|
|
| 126. Christopher R. Cunningham |
Ph.D. |
2004 |
Steven R. Myers, Ph.D. |
Hemoglobin adducts and the role of genotype in the modification of risk associated with tobacco smoke exposure to the fetus |
|
|
|
|
|
| 125. Xiaoyan (Nina) Li |
Ph.D. |
2004 |
Paul N. Epstein, Ph.D. |
The roles of pancreatic beta cell antioxidants in islet transplantation and type 1 diabetes |
|
|
|
|
|
| 124. Kristin J. Metry |
M.S. |
2004 |
David W. Hein, Ph.D. |
NAT polymorphism in breast cancer risk |
|
|
|
|
|
| 123. Wei (Wendy) Yuan Chang |
M.S. |
2004 |
Theresa S. Chen, Ph.D. |
Mechanism of oxidative stress induced cell toxicity |
|
|
|
|
|
| 122. Jennifer A. Loehle |
M.S. |
2004 |
David W. Hein, Ph.D. |
Pediatric pharmacogenetic studies: The advent of genomics, clinical implications and current initiatives in research |
|
|
|
|
|
| 121. April K. Hartford |
Ph.D. |
2004 |
Nicholas A. Delamere, Ph.D. |
NA,K-ATPase Alpha 2: Its role in calcium homeostasis, signalling and cell survival in astrocytes |
|
|
|
|
|
| 120. Laila Elsherif |
Ph.D. |
2004 |
Y. James Kang, Ph.D. |
Dietary copper restriction-induced cardiomyopathy and its reversibility in mice |
|
|
|
|
|
| 119. Jian Li |
Ph.D. |
2003 |
John W. Eaton, Ph.D. |
Oxygen toxicity and mitochondrial metabolism |
|
|
|
|
|
| 118. Yu (Janet) Zang |
M.S. |
2003 |
David W. Hein, Ph.D. |
Mechanistic studies on the T341C (Ile114Thr) single nucleotide polymorphism of human N-acetyltransferase 2 |
|
|
|
|
|
| 117. Rundong (Ray) Zhang |
M.S. |
2003 |
Zhao-Hui (Joe) Song, Ph.D. |
Cysteine 89(2.69) in the second transmembrane domain of human CB2 receptor is exposed in the ligand binding crevice |
|
|
|
|
|
| 116. Hainan Chen |
Ph.D. |
2003 |
Paul N. Epstein, Ph.D. |
Studies on the effects of pancreatic beta cell antioxidant transgenes on experimental models of diabetes |
|
|
|
|
|
| 115. Terry L. Wright, Jr. |
M.S. |
2003 |
Gavin E. Arteel, Ph.D. |
The TNFalpha paradox in ischemic heart disease |
|
|
|
|
|
| 114. Denise R. Clark |
M.S. |
2003 |
W. Glenn McGregor, M.D. |
Ribozyme-mediated REV1L inhibition reduces UV-induced mutations in the human HPRT gene |
|
|
|
|
|
| 113. Paul C. Porter |
M.S. |
2003 |
J. Christopher States, Ph.D. |
Detection and functional analysis of polymorphic XPA alleles |
|
|
|
|
|
| 112. Jason C. Lambert |
Ph.D. |
2003 |
Y. James Kang, Ph.D. |
Zinc inhibition of acute ethanol-induced liver injury |
|
|
|
|
|
| 111. Yuanqi Zhu |
M.S. |
2002 |
David W. Hein, Ph.D. |
Functional characterization of NAT gene polymorphisms |
|
|
|
|
|
| 110. Xiaoyan (Nina) Li |
M.S. |
2002 |
Paul N. Epstein, Ph.D. |
Metallotheionein overexpression prolongs grafts survival in the early phase of pancreatic islet transplantation |
|
|
|
|
|
| 109. Bradley G. Brewer |
M.S. |
2002 |
Peter P. Rowell, Ph.D. |
Short-term distribution of nicotine in the rat |
|
|
|
|
|
| 108. Xia (Clare) Shen |
M.S. |
2002 |
Paul N. Epstein, Ph.D. |
Proteomics and morphology demonstrate mitochondrial changes in diabetic cardiomyopathy |
|
|
|
|
|
| 107. Hana H. Khaled |
M.S. |
2002 |
William M. Pierce, Ph.D. |
Osteoporosis: An overview of prevention, genetics, and treatment |
|
|
|
|
|
| 106. Hainan Chen |
M.S. |
2002 |
Paul N. Epstein, Ph.D. |
Metallothionein protection against streptozotocin induced pancreatic beta cell damage and diabetes |
|
|
|
|
|
| 105. Jason R. Neale |
Ph.D. |
2002 |
William M. Pierce, Ph.D. |
Bone-targeted estrogens: Structure-activity relationships and mechanistic studies |
|
|
|
|
|
| 104. Jian Li |
M.S. |
2002 |
John W. Eaton, Ph.D. |
Mitochondrial metabolism and oxygen toxicity |
|
|
|
|
|
| 103. Yining Hou |
Ph.D. |
2002 |
Nicholas A. Delamere, Ph.D. |
The influence of cytoplasmic calcium on H+-ATPase; and the influence of H+-ATPase inhibition on sodium transport in non-pigmented ciliary epithelial cells |
|
|
|
|
|
| 102. Alfred A. Jacobs, Jr. |
Ph.D. |
2001 |
Michael E. Brier, Ph.D. |
Influence of cyclosporin on renal hemodynamics in the isolated perfused kidney |
|
|
|
|
|
| 101. Jason C. Lambert |
M.S. |
2001 |
Y. James Kang, Ph.D. |
Zinc inhibition of caspase-3 activation does not prevent apoptotic cell death |
|
|
|
|
|
| 100. E. Cristian Campian |
M.S. |
2001 |
Frederick W. Benz, Ph.D. |
Acute acrylonitrile toxicity: inhibition of glyceraldehyde- 3-phosphate dehydrogenase activity in vitro |
|
|
|
|
|
| 99. Laila Elsherif |
M.S. |
2001 |
Y. James Kang, Ph.D. |
Metallothionein protection against cadmium cardiotoxicity |
|
|
|
|
|
| 98. R. Scot Payne |
Ph.D. |
2001 |
Avital Schurr, Ph.D. |
The corticosterone hypothesis of hyperglycemia-enhanced cerebral ischemic damage |
|
|
|
|
|
| 97. Xin Fu |
Ph.D. |
2001 |
Walter M. Williams, M.D., Ph.D. |
Para-Aminophenol-induced hepatotoxicity in hamsters |
|
|
|
|
|
| 96. Xichun Sun |
Ph.D. |
2001 |
Y. James Kang, Ph.D. |
Metallothionein protection of the heart from ischemia/reperfusion injury: Cellular and molecular mechanisms |
|
|
|
|
|
| 95. John P. Hennion |
M.S. |
2001 |
Rif El-Mallakh, M.D. |
Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage |
|
|
|
|
|
| 94. April K. Hartford |
M.S. |
2000 |
Nicholas A. Delamere, Ph.D. |
Calcium signaling in astrocytes of the optic nerve head; Evidence for a role for Na,K-ATPase Alpha-2 |
|
|
|
|
|
| 93. Jason R. Neale |
M.S. |
2000 |
William M. Pierce, Ph.D. |
A novel bone selective estrogen: A candidate compound for the treatment of osteopenia |
|
|
|
|
|
| 92. Adrian J. Fretland |
Ph.D. |
2000 |
David W. Hein, Ph.D. |
Pharmacogenetics of heterocyclic amine carcinogenesis |
|
|
|
|
|
| 91. Joseph A. Spinnato, III |
Ph.D. |
1999 |
Steven R. Myers, Ph.D |
Microsomal metabolism and tissue distribution of N-Methyl-N-2,4,6-tetranitroaniline (tetryl) |
|
|
|
|
|
| 90. Matthew A. Leff |
Ph.D. |
1999 |
David W. Hein, Ph.D. |
Molecular genetics of N-acetyltransferases and prostate cancer |
|
|
|
|
|
| 89. Jian Cai |
Ph.D. |
1999 |
Harrell E. Hurst, Ph.D. |
N-(carboxymethyl)valine adduct in hemoglobin: A biomarker of advanced glycation end product formation and oxidative stress |
|
|
|
|
|
| 88. Jungyu Li |
Ph.D. |
1999 |
Frederick W. Benz, Ph.D. |
Acrylonitrile acute intoxication: Toxicodynamics and the effects of antidotes |
|
|
|
|
|
| 87. Nicolas Melo |
M.S. |
1999 |
Walter M. Williams, M.D., Ph.D. |
Prevention of acetaminophen-induced hepatotoxicity by S-(2-hydroxyethylmercapto)-L-cysteine |
|
|
|
|
|
| 86. David A. Hasselbacher |
M.S. |
1998 |
George R. Aronoff, M.D. |
The development of a dosing model for the anticoagulant heparin using neural networks |
|
|
|
|
|
| 85. Emiko Lynn Kreklau |
Ph.D. |
1997 |
Y. James Kang, Ph.D. |
Cross-resistance to adriamycin in cadium-resistant human lung carcinoma A549 cells |
|
|
|
|
|
| 84. Qiang Wu |
Ph.D. |
1997 |
Nicholas A. Delamere, Ph.D. |
Studies of carbonic anhydrases and intracellular pH regulation in non-pigmented ciliary epithelial cells |
|
|
|
|
|
| 83. Mary Manlei Li |
Ph.D. |
1997 |
Avital Schurr, Ph.D. |
Global cerebral ischemia and neuroprotection |
|
|
|
|
|
| 82. Sue Han |
Ph.D. |
1997 |
Laurence A. Carr, Ph.D. |
Regulation of the dopamine neuronal transporter in the striatum |
|
|
|
|
|
| 81. Chandrika Srinivasan |
Ph.D. |
1997 |
Theresa S. Chen, Ph.D. |
Prevention of acetylaminophen-induced toxicity by n-propylthiazolidine carboxylic acid |
|
|
|
|
|
| 80. Yining Hou |
M.S. |
1997 |
Nicholas A. Delamere, Ph.D. |
Solutes transport mechanism in nonpigmented ciliary epithelium: influence of ascorbic acid uptake on sodium transport |
|
|
|
|
|
| 79. Maureen Li |
Ph.D. |
1996 |
Peter P. Rowell, Ph.D. |
Effect of chronic nicotine treatment on rat brain nicotine acetylcholine receptors |
|
|
|
|
|
| 78. Ray Kemper |
Ph.D. |
1995 |
Harrell E. Hurst, Ph.D. |
Effects of xenobiotic induction in metabolic activation and detoxification of ethyl carbamate |
|
|
|
|
|
| 77. Hong Song |
Ph.D. |
1994 |
Theresa S. Chen, Ph.D. |
Mouse and rat differences in p-aminophenol-induced liver and kidney toxicities |
|
|
|
|
|
| 76. Jing Dong |
Ph.D. |
1994 |
Nicholas A. Delamere, Ph.D. |
Solute transport mechanism in non-pigmented ciliary epithelium |
|
|
|
|
|
| 75. Yun Meng |
Ph.D. |
1994 |
Walter M. Williams, M.D., Ph.D. |
Elimination of uridine, thymidine and thymine by the isolated perfused rat liver |
|
|
|
|
|
| 74. David B. Gazak |
Ph.D. |
1993 |
Walter M. Williams, M.D., Ph.D. |
Pharmacological modulation of hepatic pyrimidine metabolism |
|
|
|
|
|
| 73. Cathy Ann Rouze Spigarelli |
M.S. |
1993 |
Carlo Tamburro, M.D. |
An investigation of nickel toxicity: an invitro study with escherichia coli |
|
|
|
|
|
| 72. Di Chen |
Ph.D. |
1992 |
William M. Pierce Jr., Ph.D. |
Effects of zinc on bone metabolism |
|
|
|
|
|
| 71. Qusai Al-Mahasneh |
M.S. |
1991 |
George R. Rodgers, M.D., Ph.D. |
The role of activated charcoal in the treatment of acute arsenic poisoning: an in vivo study |
|
|
|
|
|
| 70. Mary Kathleen King Kaysinger |
Ph.D. |
1991 |
William M. Pierce Jr., Ph.D. |
Regulation of bone prolyl-4-hydroxylase activity by 2-oxoglutarate |
|
|
|
|
|
| 69. Rachelle J. Sells Galvin |
Ph.D. |
1990 |
Warren K. Ramp, Ph.D. |
Effects of prolyhydroxylase inhibitors extracted from tobacco on bone collagen synthesis |
|
|
|
|
|
| 68. Mordechai Sharir |
Ph.D. |
1990 |
William M. Pierce Jr., Ph.D. |
Novel thiadiazole sulfonamide carbonic anhydrase inhibitors as topically effective ocular hypotensive agents (glaucoma) |
|
|
|
|
|
| 67. Chong Zhang |
Ph.D. |
1990 |
Guandershan Thind, M.D. |
Effects of cadmium on the renal and skeletal muscle microcirculation in rats |
|
|
|
|
|
| 66. James M. Joly II |
Ph.D. |
1989 |
Walter M. Williams, M.D., Ph.D. |
Elimination of 5-ethylpyridimidines and 5-methylpyrimidines by the isolated perfused rat liver |
|
|
|
|
|
| 65. Mark J. Klan |
Ph.D. |
1988 |
Donald E. Nerland, Ph.D. |
Microsomal carbinol dehydrogenase: isolation and possible role in xenobiotic toxicity |
|
|
|
|
|
| 64. Karl G. Csaky |
Ph.D. |
1987 |
Walter M. Williams, M.D., Ph.D. |
Metabolism of fluorodeoxyuridine by the isolated perfused rat liver |
|
|
|
|
|
| 63. Charles R. Ashby, Jr. |
Ph.D. |
1987 |
Laurence A. Carr, Ph.D. |
Alteration of serotoninergic mechanisms in premenstrual syndrome (PMS) |
|
|
|
|
|
| 62. Elizabeth D. Dunlap |
Ph.D. |
1987 |
Michael A. Pfeifer, M.D. |
Biochemical and physiological change associated with diabetes in the diabetic BB rat |
|
|
|
|
|
| 61. Fu-Hsiung Lin |
Ph.D. |
1987 |
Walter M. Williams, M.D., Ph.D. |
Fluorodeoxyuridine catabolism by isolated intestinal and tumor cells |
|
|
|
|
|
| 60. John J. Schlager |
Ph.D. |
1987 |
Harrell E. Hurst, Ph.D. |
Elimination of acetaminophen by the isolated perfused rat liver in the absence and presence of ethanol |
|
|
|
|
|
| 59. Michael S. Wells |
Ph.D. |
1986 |
Donald E. Nerland, Ph.D. |
Benzene metabolism and toxicity after inhalation exposure: analysis at steady-state |
|
|
|
|
|
| 58. Donald E. Walters |
Ph.D. |
1986 |
Laurence A. Carr, Ph.D. |
Neurochemical development in the rat following perinatal exposure to marihuana |
|
|
|
|
|
| 57. Frank LaCreta |
Ph.D. |
1986 |
Walter M. Williams, M.D., Ph.D. |
Effect of nucleoside phosphorylase inhibitors on hepatic fluoropyridmidine elimination |
|
|
|
|
|
| 56. Ching-hsuen Chu |
M.S. |
1986 |
Warren K. Ramp, Ph.D. |
The interrelationships of calcium release and glucose metabolism in bone |
|
|
|
|
|
| 55. Cynthia L. Wabner |
Ph.D. |
1986 |
Theresa S. Chen, Ph.D. |
Aging changes n renal function and structure |
|
|
|
|
|
| 54. Barbour S. Warren |
Ph.D. |
1985 |
Walter M. Williams, M.D., Ph.D. |
Fluoropyrimidine disposition: dose and flow dependence |
|
|
|
|
|
| 53. Nancy A. Muma |
Ph.D. |
1985 |
Peter P. Rowell, Ph.D. |
Pharmacological, biochemical, morphological and behavioral effects on long-term choline and lecithin administration on the aged central cholinergic nervous system |
|
|
|
|
|
| 52. Brian J. Lukey |
Ph.D. |
1985 |
Harrell E. Hurst, Ph.D. |
Predictors of plasma and tissue concentrations of nortriptyline and 10-OH metabolites |
|
|
|
|
|
| 51. James A. Blank |
Ph.D. |
1985 |
Leonard C. Waite, Ph.D. |
Calcium metabolism by the avian embryo |
|
|
|
|
|
| 50. Michael J. Kelley |
Ph.D. |
1984 |
Theresa S. Chen, Ph.D. |
Effects of 5-Thio-D-glucose on hexose transport and metabolism |
|
|
|
|
|
| 49. Sayed Daoud |
Ph.D. |
1984 |
Kee Chang Huang, M.D., Ph.D. |
Adriamycin: pharmacological studies on liver, kidney and heart |
|
|
|
|
|
| 48. Brian J. Lukey |
M.S. |
1983 |
Harrell E. Hurst, Ph.D. |
Sources of variability in plasma concentration measurements of nortriptyline and 10-hydroxylated metabolites |
|
|
|
|
|
| 47. David R. Jones |
Ph.D. |
1983 |
Harrell E. Hurst, Ph.D. |
Tissue distribution and toxicokinetics of nortriptyline |
|
|
|
|
|
| 46. Michael W. McWilliams |
M.S. |
1983 |
Theresa S. Chen, Ph.D. |
Preservation of microsomal enzyme activities in rat liver by WR-2721 following gamma-irradiation |
|
|
|
|
|
| 45. Mostafa Z. Badr |
Ph.D. |
1983 |
Thomas G. Scharff, Ph.D. |
Cellular penetration and toxicity of benzoic and salicyclic acids |
|
|
|
|
|
| 44. Christopher J. Kemper |
Ph.D. |
1983 |
Donald E. Nerland, Ph.D. |
Studies concerning the metabolism and kinetics of benzene in the mouse |
|
|
|
|
|
| 43. Adrian B. VanBakel |
Ph.D. |
1983 |
William J. Waddell, M.D. |
Renal vascular activity of bis substituted (3,4-dimethoxybenzyl)cycloalkylamine and heterocyclic amine hydrochlorides |
|
|
|
|
|
| 42. Lois E. Bolcsak |
Ph.D. |
1982 |
Donald E. Nerland, Ph.D. |
Benzene toxicity:emphasis on cytosolic dihydrodiol dehydrogenases |
|
|
|
|
|
| 41. Stanley D. Erk |
Ph.D. |
1982 |
Charles H. Jarboe, Ph.D. |
Toxicokinetic study of 1,2-propanediol dinitrate (PGDN) in the dog |
|
|
|
|
|
| 40. Michael P. Lachance |
Ph.D. |
1982 |
William J. Waddell, M.D. |
Whole-body localization of caffeine in the mouse |
|
|
|
|
|
| 39. Mahmood H. Al-Wathiqui |
Ph.D. |
1982 |
William J. Waddell, M.D. |
Effects of total parenteral nutrition on pharmacokinetics of drugs |
|
|
|
|
|
| 38. Sonia R. Teller |
Ph.D. |
1982 |
Charles H. Jarboe, Ph.D. |
Synthesis and peripheral cardiovascularization of cis- and trans-2-(3,4-dimethoxybenzyl)cycloalkylamine hydrochlorides |
|
|
|
|
|
| 37. David R. Jones |
M.S. |
1981 |
Harrell E. Hurst, Ph.D. |
Human pharmacokinetics of clovoxamine |
|
|
|
|
|
| 36. William M. Pierce, Jr. |
Ph.D. |
1981 |
Leonard C. Waite, Ph.D. |
Effects of heterocyclic sulfonamides on bone metabolism |
|
|
|
|
|
| 35. Steven M. Leventer |
Ph.D. |
1981 |
Peter P. Rowell, Ph.D. |
Investigations of the human placental cholinergic system |
|
|
|
|
|
| 34. Raymond M. David |
Ph.D. |
1981 |
Donald E. Nerland, Ph.D. |
Induction of hepatic glutathione S-transferase by ethanol |
|
|
|
|
|
| 33. David C. May |
Ph.D. |
1981 |
Charles H. Jarboe, Ph.D. |
Some aspects of rabbit and human methylxanthine pharmacokinetics |
|
|
|
|
|
| 32. Maralyn E. Kaufman |
Ph.D. |
1980 |
Kee Chang Huang, M.D., Ph.D. |
Effects of glucagon on the electrical and transport properties of the intestine |
|
|
|
|
|
| 31. Harriet Tobias |
Ph.D. |
1980 |
Laurence A. Carr, Ph.D. |
The interaction of gonadal steroids and catecholamine neurons on release of luteinizing hormone and prolactin |
|
|
|
|
|
| 30. Margaret M. Schweri |
Ph.D. |
1980 |
Laurence A. Carr, Ph.D. |
Inhibition of monoamine synthesis of cycloheximide and anisomycin:possible mechanisms of action |
|
|
|
|
|
| 29. Gary E. Duncan |
Ph.D. |
1980 |
Peter P. Rowell, Ph.D. |
The subcellular distribution and release of newly synthesized acetylcholine in rat cerebral cortical synaptosomes |
|
|
|
|
|
| 28. Barbara Wenzak |
Ph.D. |
1980 |
Kee Chang Huang, M.D., Ph.D. |
The renal excretion of methotrexate |
|
|
|
|
|
| 27. Susan M. Wehry |
M.S. |
1979 |
Laurence A. Carr, Ph.D. |
The effects of amnesic agents and d-amphetamine on brain catecholamines in two mouse strains |
|
|
|
|
|
| 26. Michael J. Bannon |
M.S. |
1978 |
Charles H. Jarboe, Ph.D. |
Central nervous system action of 2,5-bis-(3,4-dimethoxybenzyl)cyclopentyl amine, a peripheral dopamine blocking agent |
|
|
|
|
|
| 25. Mark D. Lineberry |
Ph.D. |
1978 |
Leonard C. Waite, Ph.D. |
Effects of carbonic anhydrase inhibitors on calcium metabolism |
|
|
|
|
|
| 24. Paul H. Lungren |
M.S. |
1978 |
Laurence A. Carr, Ph.D. |
The effects of anisomycin and central nervous stimulants on brain catecholamine synthesis |
|
|
|
|
|
| 23. Andrew M. Connor |
M.S. |
1975 |
Curtis A. Sigdestad, Ph.D. |
The enhancement of gamma radiation by procarbazine hydrochloride |
|
|
|
|
|
| 22. Aaron E. Lucas |
M.S. |
1974 |
John A. Nicholson, Ph.D. |
The effects of acute and chronic morphine administration on the cardiovascular system of the dog |
|
|
|
|
|
| 21. Chung Sim Kim |
M.S. |
1973 |
Kee Chang Huang, M.D., Ph.D. |
A cerebroventricular perfusion technique for studying L-tryrosine transport into the ventricle |
|
|
|
|
|
| 20. James A. Schaefer |
M.S. |
1973 |
Charles H. Jarboe, Ph.D. |
Some aspects of S-(-)-nicotine biochemorphology |
|
|
|
|
|
| 19. Yun-Lai Chan |
Ph.D. |
1971 |
Kee Chang Huang, M.D., Ph.D. |
Microperfusion and micropuncture studies of renal tubular transport of tryptophan derivatives |
|
|
|
|
|
| 18. Theresa S.T. Chen |
Ph.D. |
1971 |
Kee Chang Huang, M.D., Ph.D. |
Ion transport across the intestinal mucosa of fish |
|
|
|
|
|
| 17. Walter M. Williams |
Ph.D. |
1970 |
Kee Chang Huang, M.D., Ph.D. |
Structural specificity in the renal tubular transport of tryptophan derivatives |
|
|
|
|
|
| 16. George P. Casten |
Ph.D. |
1969 |
Thomas G. Scharff, Ph.D. |
Hexose-induced delay of hexose monophosphate fermentation in dialysed yeast extract |
|
|
|
|
|
| 15. Gloria D. Sells |
Ph.D. |
1969 |
Kee Chang Huang, M.D., Ph.D. |
Studies of the development of intestinal transport |
|
|
|
|
|
| 14. John A. Nicholson |
Ph.D. |
1969 |
Charles H. Jarboe, Ph.D. |
Pharmacological properties of viburnum |
|
|
|
|
|
| 13. Patrick E. Bentley |
Ph.D. |
1968 |
Peter K. Knoefel, M.D. |
Liberation of histamine as a mechanism of the toxic action of radiopaque diagnostic agents |
|
|
|
|
|
| 12. Kenneth L. Bailey |
Ph.D. |
1968 |
Peter K. Knoefel, M.D. |
Hippuric acid secretion in the mammalian kidney |
|
|
|
|
|
| 11. Karimullah Abd Zirvi |
Ph.D. |
1968 |
Charles H. Jarboe, Ph.D. |
Centrally active imides and amides of certain cyclobutanecarboxylic acids |
|
|
|
|
|
| 10. Raymond L. Woosley |
Ph.D. |
1967 |
Kee Chang Huang, M.D., Ph.D. |
Renal tubular transport of hexoses |
|
|
|
|
|
| 9. David N. Johnson |
M.S. |
1966 |
Richard P. Smith, Ph.D. |
The sympathetic innervation of the rabbit seminal vesicle |
|
|
|
|
|
| 8. Mahmoud Oskoui |
Ph.D. |
1965 |
Peter K. Knoefel, M.D. |
Nephrotic action of a synthetic plastic material and some of its constituents |
|
|
|
|
|
| 7. Lin Min Chen |
M.S. |
1965 |
Paul G. LeFevre, Ph.D. |
Reactions of red cell sugar transport system with non-transported analogues |
|
|
|
|
|
| 6. Robert L. Moffitt |
Ph.D. |
1964 |
Thomas G. Scharff, Ph.D. |
Reinvestigation of certain aspects of fermentation in yeast extracts |
|
|
|
|
|
| 5. David Ling |
M.S. |
1964 |
Kee Chang Huang, M.D., Ph.D. |
Biliary excretion of organic acids |
|
|
|
|
|
| 4. Alan R. Kolber |
Ph.D. |
1964 |
Paul G. LeFevre, Ph.D. |
Evidence for carrier-mediated transport of monosaccharides in the Ehrlich ascitis tumor cell |
|
|
|
|
|
| 3. Linda Cohen |
M.S. |
1963 |
Kee Chang Huang, M.D., Ph.D. |
Intestinal absorption of tryptophan and its derivatives |
|
|
|
|
|
| 2. Hubert J. Wolfe |
M.S. |
1959 |
Kee Chang Huang, M.D., Ph.D. |
The metabolism of the aminobenzoic acids in the adult and embryonic gallus domesticus |
|
|
|
|
|
| 1. James W. Fisher |
Ph.D. |
1958 |
Peter K. Knoefel, M.D. |
The influence of the adrenocortical hormones on cobalt polycythemia |
|
|
|
|
|
